In Vitro Systems for Detection of Antitumour Drugs

Bradner W.T. (1978). New prescreens for antitumour antibiotics. Proc. 10th Int. Congr. Chemother. (in press)

Buskirk H.H. (1969). Assay of cytotoxic agents with L1210 cells. Proc. Tissue Culture Assoc. 20, 23

Di Marco A. , Zunio F. , and Casazza A.M. (1978). Comparison of biochemical and biological methods in the evaluation of new anthracycline drugs. Proc. 10th Int. Congr. Chemother. (in press)

Eagle H. , and Foley G.E. (1956). The cytotoxic action of carcinolytic agents in tissue culture. Am. J. Med. 21, 739–749

Fleck W. (1969). E. Coli - Zellum mit intaktem und defektem dunkelreparaturmechanismus für strukturschäden an der DNS als screeni-modell für die suche nach potentiellen carcinostatica. Zeitschr. Allg. Mikrobiol. 9, 217–221.

Gause G.F. (1978). Yeast mutants with distorted cell membranes as detection systems for anti tumour antibiotics. Proc. 10th Int. Congr. Chemother. (in press)

Gause G.F. , Laiko A.V. , and Selesneva T.I. (1976). Yeast Mutants with distorted cell membranes as tests in the screening for anti tumour antibiotics. Cancer Chemother. Rep. 60, 637–638

Grady J.E. , Lummis W.L. , and Smith C.G. (1960). Tissue culture bioautographic system. Proc. Soc. Exp. Biol. & Med. 103, 727–730

Hanka L.J. (1967). In vitro screen for antimetabolites. Proc. 5th Int. Congr. Chemother. pp 351–35, Vienna

Hanka L.J. (1974). Results of in vitro screening for antimetabolites. Proc. 5th Int. Congr. Chemother., Daikos G.K. ed., Vol. 3, pp 118–122, Helenic Society for Chemotherapy Athens

Hanka L.J. , Evans J.S. , Mason D.J. , and Dietz A. (1966). Microbiological production of 5-azacytidine. I. Production and biological activity. Antimicrobial Agents & Chemotherapy pp 619–624 American Society of Microbiology Ann Arbor.

Hanka L.J. , and Dietz A. (1976). U-43, 120: a new anti tumour antibiotic. I. Production, biological activity, microbial assay and taxonomy of the producing micro-organism. J. Antibiot. (Japan) 29, 611–617

Heinemann B. (1971). Prophage induction in lysogenic bacteria as a method of detecting potential mutagenic, carcinogenic, carcinostatic and teratogenic agents in Chemical Mutagens, Hollaender A. , ed., vol. 1, pp 235–266, Plenum Press New York.

Marks P.A. , Rifkind R.A. , Reuben R. , Breslow R. , Terada M. , Cobb W. , and Bogden A.E. (1978). Induction of murine erythroleukemia cells to differentiate: A model for the detection of new antitumour drugs. Proc. 10th Int. Congr. Chemother. (in press)

Martin D.G. , Hanka L.J. , and Neil G.L. (1974). A new anti tumour agent (α 4s, 5r)-α - amino-3-chloro-4-hydroxy-4, 5-dihydro-5-isoacid (NSC - 176324): preliminary evaluation against L1210 mouse leukemia in vivo. Cancer Chemother. Rep. 58, 935–937

Smith C.G. , Lummis W.L. , and Grady J.E. (1959). An improved tissue culture assay. I. Methodology & cytotoxicity of antitumour agents. Cancer Res. 19, 843–846

Umezawa H. (1978). Enzymic screening methods for microbial products enhancing cancer immunity and therapeutic effect of antitumour agents. Proc. 10th Int. Congr. Chemother. (in press)